The clinical prognostic significance of miR-140-5p expression in patients with cancer: A Meta and Bioinformatic analysis.
Pathol Res Pract
; 261: 155475, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39067174
ABSTRACT
The prognostic value of microRNA-140-5p (miR-140-5p) expression in cancer patients has been investigated, but with inconsistent results. This meta-analysis aims to determine the prognostic significance of miR-140-5p expression in patients with various malignancies. A comprehensive literature search was conducted using PubMed, Web of Science, ProQuest, Cochrane, and Google Scholar to identify relevant studies published before June 2023. Pooled hazard ratios (HR) and odds ratios (OR) with 95â¯% confidence intervals (CI) were calculated to assess the prognostic importance and clinicopathological features of miR-140-5p in overall survival (OS) and disease-free survival (DFS) of cancer patients, respectively. The CancerMIRNome database and other OS analysis webservers were utilized to explore the prognostic value and expression profile of miR-140-5p. A total of 17 studies were included in the final analysis. The results demonstrated that decreased miR-140-5p expression was significantly associated with inferior OS (pooled HR 0.63; 95â¯% CI, 0.51-0.79; p < 0.001) and DFS (pooled HR 0.40; 95â¯% CI, 0.25-0.64; p < 0.001). Pooled ORs indicated a significant correlation between reduced miR-140-5p expression and positive lymph node metastasis (LNM; OR = 3.42; 95â¯% CI, 2.36-4.94; p < 0.001), advanced tumor stage (OR = 2.80; 95â¯% CI, 2.07-3.78; p < 0.001), and positive distant metastasis (DM; OR = 10.81; 95â¯% CI, 3.31-35.30; p < 0.001). No significant associations were observed between miR-140-5p expression and gender (OR = 0.94; 95â¯% CI, 0.70-1.28; p = 0.70), age (OR = 1.31; 95â¯% CI, 0.99-1.74; p = 0.06), tumor size (OR = 1.55; 95â¯% CI, 0.77-3.10; p = 0.22), and histological grade (OR = 1.20; 95â¯% CI, 0.46-3.10; p = 0.71). Subgroup analyses revealed that decreased miR-140-5p expression was associated with shorter OS in subgroups based on sample size (<100 or >100), tumor origin (GI or non-GI), and cancer type (GC/CRC). Bioinformatic analysis supported the finding that miR-140-5p was downregulated in most tumor tissues, and its reduced expression was linked to poor prognosis in patients with multiple malignancies. The prognostic significance of miR-140-5p in predicting reduced OS and DFS suggests that measuring miR-140-5p expression levels before treatment could serve as a valuable biomarker for identifying cancer patients with an unfavorable prognosis and improving clinical management.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Biomarcadores Tumorais
/
Biologia Computacional
/
MicroRNAs
/
Neoplasias
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article